Notably, studies investigating the potential association between VEGF polymorphisms and circulating VEGF levels also led to controversial results [68,69,70], opening new opportunities for further investigations to clarify the role of germline VEGF variations in NSCLC progression and its repercussion in VEGF levels. Here, VEGFA is linked to non-small cell lung carcinoma.